DK509485A - Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse - Google Patents

Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse Download PDF

Info

Publication number
DK509485A
DK509485A DK509485A DK509485A DK509485A DK 509485 A DK509485 A DK 509485A DK 509485 A DK509485 A DK 509485A DK 509485 A DK509485 A DK 509485A DK 509485 A DK509485 A DK 509485A
Authority
DK
Denmark
Prior art keywords
diones
acyloxy
hydroxy
preparation
androsten
Prior art date
Application number
DK509485A
Other languages
English (en)
Other versions
DK162510C (da
DK509485D0 (da
DK162510B (da
Inventor
Leo Geller
Peter Glanzmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK509485D0 publication Critical patent/DK509485D0/da
Publication of DK509485A publication Critical patent/DK509485A/da
Publication of DK162510B publication Critical patent/DK162510B/da
Application granted granted Critical
Publication of DK162510C publication Critical patent/DK162510C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Magnetic Record Carriers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK509485A 1984-11-06 1985-11-05 Toerstoffer til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner, fremgangsmaade til fremstilling af toersofferne samt suspensioner fremstillet ud fra toerstofferne DK162510C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530584 1984-11-06
CH530584 1984-11-06

Publications (4)

Publication Number Publication Date
DK509485D0 DK509485D0 (da) 1985-11-05
DK509485A true DK509485A (da) 1986-05-07
DK162510B DK162510B (da) 1991-11-11
DK162510C DK162510C (da) 1992-03-30

Family

ID=4291364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK509485A DK162510C (da) 1984-11-06 1985-11-05 Toerstoffer til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner, fremgangsmaade til fremstilling af toersofferne samt suspensioner fremstillet ud fra toerstofferne

Country Status (26)

Country Link
US (1) US5002940A (da)
EP (2) EP0181287B1 (da)
JP (2) JPS61204118A (da)
KR (1) KR890000907B1 (da)
AT (2) ATE51152T1 (da)
AU (2) AU586988B2 (da)
CA (1) CA1249223A (da)
CY (2) CY1898A (da)
DD (1) DD244292A5 (da)
DE (2) DE3576650D1 (da)
DK (1) DK162510C (da)
ES (1) ES8701491A1 (da)
FI (1) FI85809C (da)
GR (1) GR852637B (da)
HK (2) HK101192A (da)
HU (1) HU195728B (da)
IE (2) IE63156B1 (da)
IL (1) IL76943A (da)
MX (1) MX9203371A (da)
NL (1) NL940015I2 (da)
NO (1) NO169324C (da)
NZ (2) NZ229276A (da)
PH (1) PH21673A (da)
PT (1) PT81429B (da)
SG (1) SG107192G (da)
ZA (1) ZA858481B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH673395A5 (da) * 1987-01-30 1990-03-15 Ciba Geigy Ag
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
AU1787800A (en) * 1998-12-08 2000-06-26 Phares Pharmaceutical Research N.V. Phospholipid compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
US6487907B1 (en) * 1999-07-08 2002-12-03 California Institute Of Technology Microgyroscope with integrated vibratory element
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
WO2019213286A1 (en) * 2018-05-02 2019-11-07 LifeMax Laboratories, Inc. Extended release suspension formulation of lurasidone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
LU77457A1 (da) * 1977-05-31 1979-01-19
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3339295A1 (de) * 1982-11-15 1984-05-17 Schering AG, 1000 Berlin und 4709 Bergkamen 4-hydroxy- und 4-acyloxy-4-androsten-3,17-dione zur verwendung bei der prophylaxe und therapie der prostatahyperplasie und diese enthaltende mittel fuer derartige verwendung
DK79184A (da) * 1983-02-23 1984-08-24 Sanofi Sa Fungicide farmaceutiske midler indeholdende et imidazolderivat
EP0226021A1 (de) * 1985-12-12 1987-06-24 BBC Brown Boveri AG Thyristor mit schaltbarem Emitter-Kurzschluss

Also Published As

Publication number Publication date
EP0181287A2 (de) 1986-05-14
GR852637B (da) 1986-03-04
SG107192G (en) 1992-12-24
FI854330A0 (fi) 1985-11-04
EP0346953A3 (en) 1990-11-22
CY1677A (en) 1993-10-10
CA1249223A (en) 1989-01-24
NO854403L (no) 1986-05-07
DE3587020D1 (de) 1993-03-04
US5002940A (en) 1991-03-26
NL940015I2 (nl) 1997-01-06
NZ229276A (en) 1989-08-29
EP0346953B1 (de) 1993-01-20
IE63166B1 (en) 1995-03-22
FI85809C (fi) 1992-06-10
FI854330A (fi) 1986-05-07
AU586988B2 (en) 1989-08-03
JPS61204118A (ja) 1986-09-10
ZA858481B (en) 1986-06-25
PT81429B (pt) 1988-03-03
JPH0558410B2 (da) 1993-08-26
CY1898A (en) 1985-10-31
IE63156B1 (en) 1995-03-22
DK162510C (da) 1992-03-30
FI85809B (fi) 1992-02-28
AU4934485A (en) 1986-05-15
EP0346953A2 (de) 1989-12-20
ATE84718T1 (de) 1993-02-15
PH21673A (en) 1988-01-13
PT81429A (en) 1985-12-01
JPH0768130B2 (ja) 1995-07-26
IL76943A (en) 1990-02-09
ES8701491A1 (es) 1986-12-01
DE3576650D1 (de) 1990-04-26
DK509485D0 (da) 1985-11-05
AU4150489A (en) 1990-01-04
KR890000907B1 (ko) 1989-04-13
NZ214069A (en) 1989-08-29
HK101192A (en) 1992-12-24
DK162510B (da) 1991-11-11
HK192095A (en) 1995-12-29
EP0181287A3 (en) 1987-09-23
MX9203371A (es) 1992-09-01
AU633844B2 (en) 1993-02-11
ATE51152T1 (de) 1990-04-15
HUT42936A (en) 1987-09-28
KR860003825A (ko) 1986-06-13
NO169324B (no) 1992-03-02
IE852755L (en) 1986-05-06
ES548492A0 (es) 1986-12-01
HU195728B (en) 1988-07-28
DD244292A5 (de) 1987-04-01
JPH0648945A (ja) 1994-02-22
NL940015I1 (nl) 1994-10-17
IE902490L (en) 1986-05-06
NO169324C (no) 1992-06-10
EP0181287B1 (de) 1990-03-21

Similar Documents

Publication Publication Date Title
FI830979L (fi) Nya kvartaera 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl-norskopinetrar och foerfarande foer deraframstaellning
AR240929A1 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
DK509485A (da) Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse
AR240813A1 (es) N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento
DK483584D0 (da) Azolyl-tetrahydrofuran-2-yliden-methan-derivater, deres fremstillingog anvendelse som fungicider samt ved fremstillingen anvendelige udgangsmaterialer
FR2432505B1 (fr) Nouveaux sels de 5-iodo-3-nitro-4-hydroxybenzonitrile, leur preparation et compositions qui les contiennent
AR214828A1 (es) Mejoras en trabas regulables papara la hoja de ventiluces o similares
DK50486A (da) Stangmaterialetransportoer
ES293255Y (es) Recipiente especialmente adaptado para pegar sobres o humedecer superficies

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PUP Patent expired